Molecular mechanisms of neuronal cell death

Annals of the New York Academy of Sciences

Volumn 991, Issue , 2003, Pages 237-250

  Heidenreich, Kim A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cell death; Neuron

Indexed keywords

CYSTEINE PROTEINASE;

ANIMAL CELL; APOPTOSIS; CELL DEATH; CONFERENCE PAPER; EFFECTOR CELL; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR MECHANICS; NERVE CELL; NERVE DEGENERATION; NONHUMAN; OLIGOMERIZATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION;

ANIMALIA;

EID: 0038389591     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07480.x     Document Type: Conference Paper

References (64)

1. MOCHIZUKI, H., et al. 1996. Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137: 120-123.
2. ANGLADE, P., et al. 1997. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12: 25-31.
3. TATTON, N.A., et al. 1998. A fluorescent double-labling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann. Neurol. 44: S142-S148.
4. HIRSCH, E.C., et al. 1999. Dopaminergic neurons degenerate by apoptosis in Parkinson's disease. Mov. Disord. 14: 383-385.
5. SMALE, G., et al. 1995. Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol. 133: 225-230.
6. LASSMANN, H., et al. 1995. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. (Berlin) 89: 35-41.
7. ANDERSON, A.J., J.H. SU & C.W. COTMAN. 1996. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. 16: 1710-1719.
8. TRONCOSO, J.C., et al. 1996. In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: correlations with senile plaques and disease progression. J. Neuropathol. Exp. Neurol. 55: 1134-1142.
9. SU, J.H., G. DENG & C.W. COTMAN. 1997. Bax protein expression is increased in Alzheimer's brain: Correlations with DNA damage, Bcl-2 expression, and brain pathology. J. Neuropathol. Exp. Neurol. 56: 86-93.
10. DRAGUNOW, M., et al. 1995. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 6: 1053-1057.
11. THOMAS, L.B., et al. 1995. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp. Neurol. 133: 265-272.
12. ZEITLIN, S., et al. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat. Genet. 11: 155-163.
13. GOLDBERG, Y.P., et al. 1996. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat. Genet. 13: 442-449.
14. TROOST, D., et al. 1995. Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol. Appl. Neurobiol. 21: 498-504.
15. RABIZADEH, S., et al. 1995. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc. Natl. Acad. Sci. USA 92: 3024-3028.
16. MU, X., et al. 1996. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal chord motor neurons. Ann. Neurol. 40: 379-386.
17. GHADGE, G.D., et al. 1997. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J. Neurosci. 17: 8756-8766.
18. PASINELLI, P., et al. 1998. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc. Natl. Acad. Sci. USA 95: 15763-15768.
19. IKEDA, H., et al. 1996. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nat. Genet. 13: 196-202.
20. WELLINGTON, C.L., et al. 1998. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273: 9158-9167.
21. WARRICK, J.M., et al. 1998. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell. 93: 939-949.
22. STRASSER, A., L. O'CONNOR & V.M. DIXIT. 2000. Apoptosis signaling. Annu. Rev. Biochem. 69: 217-245.
23. GREEN, D.R. 1998. Apoptotic pathways: the roads to ruin. Cell 94: 695-698.
24. PINKOSKI, M.J. & D.R. GREEN. 1999. Fas ligand, death gene. Cell Death Differ. 6: 1174-1181.
25. CHINNAIYAN, A.M., et al. 1996. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271: 4961-4965.
26. FEINSTEIN, E., et al. 1995. The death domain: a module shared by proteins with diverse cellular functions. Trends Biochem. Sci. 20: 342-344.
27. MUZIO, M., et al. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827.
28. MUZIO, M., et al. 1998. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273: 2926-2930.
29. CAI, J., J. YANG & D.P. JONES. 1998. Mitochondrial control of apoptosis: the role of cytochrome c. Biochim. Biophys. Acta 1366: 139-149.
30. ZOU, H., et al. 1999 An APAF-1/cytochrome c multimeric complex is a functional apoptosome that activates caspase-9. J. Biol. Chem. 274: 11549-11556.
31. STENNICKE, H.R. 1998. Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem. 273: 27084-27090.
32. PAN, G., E.W. HUMKE & V.W. DIXIT. 1998. Activation of caspases triggered by cytochrome c in vitro. FEBS Lett. 426: 151-154.
33. TSUJIMOTO, Y. 1998. Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria? Genes Cells 3: 697-707.
34. WEI, M.C., et al. 2001. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730.
35. POLSTER, B.M., K.W. KINALLY & G. FISKUM. 2001. BH3 death domain peptide induces cell type-selective mitochondrial outer membrane permeability. J. Biol. Chem. 276: 37887-37894.
36. OTTER, I., et al. 1998. The binding properties and biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli. J. Biol. Chem. 273: 6110-6120.
37. ZONG, W.X., et al. 2001. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15: 1481-1486.
38. DE GIORGI, F., et al. 2002. The permeability transition pore signals apoptosis by directing Bax translocation and multimerization. FASEB J. 16: 607-609.
39. HALESTRAP, A.P., G.P. MCSTAY & S.J. CLARK. 2002. The permeability transition pore complex: another view. Biochimie 84: 153-166.
40. WALDMEIER, P. C., et al. 2002. Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. Mol. Pharmacol. 62: 22-29.
41. KETAMURA, Y., et al. 1998. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res. 780: 260-269.
42. FELDERHOFF-MUESER, U., et al. 2000. Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is upregulated following cerebral hypoxic-ischemic injury to the developing rat brain. Brain Pathol. 10: 17-29.
43. MARTIN-VILLALBA, A., et al. 1999. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19: 3809-3817.
44. PARSADANIAN, A.S., et al. 1998. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons. J. Neurosci. 18: 1009-1019.
45. WHITFIELD, J., et al. 2001. Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron 29: 629-643.
46. LINSEMAN, D.A., et al. 2002. Insulin-like growth factor-I blocks Bcl-2 interacting mediator of cell death (Bim) induction and intrinsic death signaling in cerebellar granule neurons. J. Neurosci. 22: 9287-9297.
47. HARRIS C.A. & E.M. JOHNSON, JR. 2001. BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J. Biol. Chem. 276: 37754-37760.
48. BOUILLET, P., et al. 2001. Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev. Cell. 5: 645-653.
49. LE-NICULESCU, H., et al. 1999. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol. Cell. Biol. 19: 751-763.
50. D'MELLO, S.R., et al. 1993. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. USA 90: 10989-10993.
51. STREETZ, K., et al. 2000. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 119: 446-460.
52. BRADHAM, C.A., et al. 1998. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol. Cell. Biol. 18: 6353-6364.
53. LINSEMAN, D.A., et al. 2002. Suppression of death receptor signaling in cerebellar Purkinje neurons protects neighboring granule neurons from apoptosis via an insulin-like growth factor-I dependent mechanism. J. Biol. Chem. 277: 24546-24553.
54. MILLER, T.M., et al. 1997. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J. Cell. Biol. 139: 205-217.
55. SELIMI, F., et al. 2000. Target-related and intrinsic neuronal death in Lurcher mutant mice are both mediated by caspase-3 activation. J. Neurosci. 20: 992-1000.
56. GERHARDT, E., et al. 2001. Cascade of caspase activation in potassium-deprived cerebellar granule neurons: targets for treatment with peptide and protein inhibitors of apoptosis. Mol. Cell. Neurosci. 17: 717-731.
57. KORSMEYER, S.J. 2000. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ. 7: 1166-1173.
58. DESAGHER, S., et al. 1999. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell. Biol. 144: 891-901.
59. PUTCHA, G.V., et al. 2001. Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis. Neuron 29: 615-628.
60. O'CONNOR, L., et al. 1998. Bim: A novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17: 384-395.
61. WATSON, A., et al. 1998. Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons. J. Neurosci. 18: 751-762.
62. DIJKERS, P.F., et al. 2002. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J. Cell. Biol. 156: 531-542.
63. ZHENG, W.H., S. KAR & R. QUIRION. 2000. Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells. J. Biol. Chem. 275: 39152-39158.
64. BRUNET, A., et al. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.